Annals of Internal Medicine · 1956 · 31 citations · 14 references
PharmacyPharmacotherapyAutoimmunityInflammationRheumatologyCorticosteroid PharmacologyCorticosteroid TherapySteroid PharmacologySystemic SclerosisCorticosteroid TherapeuticsPrednisolone UsePrednisone UseScleroderma TreatmentSteroid Therapy ManagementSystemic Sclerosis Skin InvolvementTherapeutic CorticosteroidsVisceral Involvement
ExcerptBoth cortisone and corticotropin have been reported as capable of inducing favorable changes in the cutaneous and visceral symptoms of patients with progressive systemic sclerosis.1-6 While some authors are of the opinion that steroid therapy has arrested progress of the disease,5 others feel that there is no fundamental alteration in the course of the illness, and most note quick return to pretreatment status when corticotropin or cortisone is discontinued.1, 3, 4, 6This report deals with the effects of a synthetic steroid, prednisone (17α,21-dihydroxy-Δ1,4-pregnadiene-3,11,20-trione), observed in six patients with progressive systemic sclerosis. Prednisone has been found to have anti-inflammatory and...
14
SCLERODERMA (BASED ON A STUDY OF OVER 150 CASES)
I Leinwand, A. Wilbur Duryee, M N RICHTER · Annals of Internal Medicine · 1954 · 256 citations
Medicine, Dermatology, Pathology +6
Hunter B. Moore · The Lancet · 1952 · 115 citations
Medicine, Nephrology, Pathology +12
J. G. Sharnoff · Journal of the American Medical Association · 1951 · 75 citations